Microchip electrophoresis separation coupled to mass spectrometry (MCE–MS) for the rapid monitoring of multiple quality attributes of monoclonal antibodies
Authors:
- 22 September 2022
- journal article
- research article
- Published by Wiley in Electrophoresis
- Vol. 43 (23-24) , 2453-2465
Abstract
Therapeutic monoclonal antibodies (mAbs) are highly heterogeneous as a result of posttranslational modifications (PTMs) during bioprocessing and storage. The modifications that impact mAb product quality are regarded as critical quality attributes and require monitoring. The conventional LC–mass spectrometer (MS) method used for product quality monitoring may require protein A purification prior to analysis. In this paper, we present a high‐throughput microchip electrophoresis (<4 min) in‐line with MS (MCE–MS) that enables baseline separation and characterization of Fc, Fd′, and light chain (LC) domains of IdeS‐treated mAb sample directly from bioreactor. The NISTmAb was used to optimize the MCE separation and to assess its capability of multiple attribute monitoring. The MCE–MS can uniquely separate and characterize deamidated species at domain level compared to LC–MS method. Two case studies were followed to demonstrate the method capability of monitoring product quality of mAb samples from stability studies or directly from bioreactors.Keywords
This publication has 41 references indexed in Scilit:
- Complementary MS Methods Assist Conformational Characterization of Antibodies with Altered S–S Bonding NetworksJournal of the American Society for Mass Spectrometry, 2013
- N-Glycan Profiling by Microchip Electrophoresis to Differentiate Disease States Related to Esophageal AdenocarcinomaAnalytical Chemistry, 2012
- Fucose content of monoclonal antibodies can be controlled by culture medium osmolality for high antibody-dependent cellular cytotoxicityCytotechnology, 2011
- Intact protein analysis in the biopharmaceutical fieldJournal of Pharmaceutical and Biomedical Analysis, 2011
- Acceptable changes in quality attributes of glycosylated biopharmaceuticalsNature Biotechnology, 2011
- Assessing monoclonal antibody product quality attribute criticality through clinical studiesmAbs, 2010
- Mass spectrometry for structural characterization of therapeutic antibodiesMass Spectrometry Reviews, 2008
- Fully Integrated Glass Microfluidic Device for Performing High-Efficiency Capillary Electrophoresis and Electrospray Ionization Mass SpectrometryAnalytical Chemistry, 2008
- Heterogeneity of Monoclonal AntibodiesJournal of Pharmaceutical Sciences, 2008
- Formation of Pyroglutamic Acid from N-Terminal Glutamic Acid in Immunoglobulin Gamma AntibodiesAnalytical Chemistry, 2006